Published in Lancet on September 14, 2011
Modeling causes of death: an integrated approach using CODEm. Popul Health Metr (2012) 3.12
Effect of VIA screening by primary health workers: randomized controlled study in Mumbai, India. J Natl Cancer Inst (2014) 2.21
Achieving high coverage in Rwanda's national human papillomavirus vaccination programme. Bull World Health Organ (2012) 2.20
Factors affecting uptake and adherence to breast cancer chemoprevention: a systematic review and meta-analysis. Ann Oncol (2015) 2.17
Cancer incidence in Nigeria: a report from population-based cancer registries. Cancer Epidemiol (2012) 1.78
Liver cirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysis. BMC Med (2014) 1.66
Cervical cancer prevention in low- and middle-income countries: feasible, affordable, essential. Cancer Prev Res (Phila) (2011) 1.50
CUL4A induces epithelial-mesenchymal transition and promotes cancer metastasis by regulating ZEB1 expression. Cancer Res (2013) 1.48
Methionine-restricted diet inhibits growth of MCF10AT1-derived mammary tumors by increasing cell cycle inhibitors in athymic nude mice. BMC Cancer (2016) 1.40
Women's health beyond reproduction: meeting the challenges. Bull World Health Organ (2012) 1.38
Changing patterns in the clinical characteristics of korean breast cancer from 1996-2010 using an online nationwide breast cancer database. J Breast Cancer (2012) 1.35
Development of an orally-administrative MELK-targeting inhibitor that suppresses the growth of various types of human cancer. Oncotarget (2012) 1.30
Upregulation of microRNA-224 is associated with aggressive progression and poor prognosis in human cervical cancer. Diagn Pathol (2013) 1.16
Integration of comprehensive women's health programmes into health systems: cervical cancer prevention, care and control in Rwanda. Bull World Health Organ (2013) 1.13
The Most Important Causes of Death in Iranian Population; a Retrospective Cohort Study. Emerg (Tehran) (2015) 1.07
Induction of apoptosis in human breast cancer cells via caspase pathway by vernodalin isolated from Centratherum anthelminticum (L.) seeds. PLoS One (2013) 1.05
Genetically modified pigs for biomedical research. J Inherit Metab Dis (2012) 1.05
Breast and cervical cancer in 187 countries between 1980 and 2010. Lancet (2012) 1.03
Methylomic analysis identifies frequent DNA methylation of zinc finger protein 582 (ZNF582) in cervical neoplasms. PLoS One (2012) 0.99
Long noncoding RNA MEG3 is downregulated in cervical cancer and affects cell proliferation and apoptosis by regulating miR-21. Cancer Biol Ther (2016) 0.99
DEAD-box helicase DP103 defines metastatic potential of human breast cancers. J Clin Invest (2014) 0.97
Bidirectional Crosstalk between the Estrogen Receptor and Human Epidermal Growth Factor Receptor 2 Signaling Pathways in Breast Cancer: Molecular Basis and Clinical Implications. Breast Care (Basel) (2013) 0.96
Proteomic analyses reveal high expression of decorin and endoplasmin (HSP90B1) are associated with breast cancer metastasis and decreased survival. PLoS One (2012) 0.96
Evaluation of breast cancer knowledge among health promoters in Mexico before and after focused training. Oncologist (2014) 0.96
Targeted PI3K/AKT/mTOR therapy for metastatic carcinomas of the cervix: A phase I clinical experience. Oncotarget (2014) 0.95
Global mortality trends and patterns in older women. Bull World Health Organ (2013) 0.94
Trichosanthin inhibits breast cancer cell proliferation in both cell lines and nude mice by promotion of apoptosis. PLoS One (2012) 0.94
Breast metastasis of a squamous cell carcinoma of the uterine cervix mimicking inflammatory breast cancer. Case Rep Oncol (2012) 0.93
Racial and Ethnic Disparities in the Impact of Obesity on Breast Cancer Risk and Survival: A Global Perspective. Adv Nutr (2015) 0.93
Prevalence and type distribution of high-risk human papillomavirus in patients with cervical cancer: a population-based study. Infect Agent Cancer (2013) 0.93
PAX1/SOX1 DNA methylation and cervical neoplasia detection: a Taiwanese Gynecologic Oncology Group (TGOG) study. Cancer Med (2014) 0.92
Cervical cancer screening among university students in South Africa: a theory based study. PLoS One (2014) 0.92
Glycoprotein non-metastatic b (GPNMB): A metastatic mediator and emerging therapeutic target in cancer. Onco Targets Ther (2013) 0.91
Developing the Evidence Base to Inform Best Practice: A Scoping Study of Breast and Cervical Cancer Reviews in Low- and Middle-Income Countries. PLoS One (2015) 0.91
Addressing the younger age at onset in breast cancer patients in Asia: an age-period-cohort analysis of fifty years of quality data from the international agency for research on cancer. ISRN Oncol (2013) 0.90
Hypoxia promotes the proliferation of cervical carcinoma cells through stimulating the secretion of IL-8. Int J Clin Exp Pathol (2014) 0.90
Differentially expressed microRNAs in the serum of cervical squamous cell carcinoma patients before and after surgery. J Hematol Oncol (2014) 0.90
Why the time is right to tackle breast and cervical cancer in low-resource settings. Bull World Health Organ (2013) 0.89
Expression of TweakR in breast cancer and preclinical activity of enavatuzumab, a humanized anti-TweakR mAb. J Cancer Res Clin Oncol (2012) 0.89
Gastric cancer incidence estimation in a resource-limited nation: use of endoscopy registry methodology. Cancer Causes Control (2012) 0.89
IL-17 suppresses immune effector functions in human papillomavirus-associated epithelial hyperplasia. J Immunol (2014) 0.89
Prevention of nodal metastases in breast cancer following the lymphatic migration of paclitaxel-loaded expansile nanoparticles. Biomaterials (2012) 0.89
Lactate dehydrogenase-B is silenced by promoter methylation in a high frequency of human breast cancers. PLoS One (2013) 0.88
Differential promoter methylation of kinesin family member 1a in plasma is associated with breast cancer and DNA repair capacity. Oncol Rep (2014) 0.88
Delays in Breast Cancer Presentation and Diagnosis at Two Rural Cancer Referral Centers in Rwanda. Oncologist (2015) 0.86
Downregulation of phosphoglycerate dehydrogenase inhibits proliferation and enhances cisplatin sensitivity in cervical adenocarcinoma cells by regulating Bcl-2 and caspase-3. Cancer Biol Ther (2015) 0.86
Comparing cancer care, outcomes, and costs across health systems: charting the course. J Natl Cancer Inst Monogr (2013) 0.86
Cervical brachytherapy exchange: steps toward oncology capacity building in Botswana. Oncologist (2014) 0.86
Activation of SNAT1/SLC38A1 in human breast cancer: correlation with p-Akt overexpression. BMC Cancer (2013) 0.85
Cervical cancer knowledge and screening behaviors among female university graduates of year 2012 attending national graduate orientation program, Bhutan. BMC Womens Health (2014) 0.85
Who and what is a "population"? Historical debates, current controversies, and implications for understanding "population health" and rectifying health inequities. Milbank Q (2012) 0.84
Evaluating the prognostic significance of FBXW7 expression level in human breast cancer by a meta-analysis of transcriptional profiles. J Cancer Sci Ther (2012) 0.84
ERβ1: characterization, prognosis, and evaluation of treatment strategies in ERα-positive and -negative breast cancer. BMC Cancer (2014) 0.84
Metastasis-Associated in Colon Cancer-1 Associates With Poor Prognosis and Promotes Cell Invasion and Angiogenesis in Human Cervical Cancer. Int J Gynecol Cancer (2015) 0.83
Integrative analysis of cancer-related signaling pathways. Front Physiol (2013) 0.83
Cervical and female breast cancers in the Americas: current situation and opportunities for action. Bull World Health Organ (2013) 0.83
Discordance of Estrogen & Progesterone Receptors After Neoadjuvant Chemotherapy in Breast Cancer- an Indian Study. Indian J Surg Oncol (2016) 0.83
Epidemiology of Breast Cancer among Bahraini Women: Data from the Bahrain Cancer Registry. Sultan Qaboos Univ Med J (2014) 0.83
Concordance analysis of methylation biomarkers detection in self-collected and physician-collected samples in cervical neoplasm. BMC Cancer (2015) 0.82
A let-7b binding site SNP in the 3'-UTR of the Bcl-xL gene enhances resistance to 5-fluorouracil and doxorubicin in breast cancer cells. Oncol Lett (2015) 0.82
Identification of differentially-expressed genes by DNA methylation in cervical cancer. Oncol Lett (2015) 0.82
Association of epigenetic inactivation of the WRN gene with anticancer drug sensitivity in cervical cancer cells. Oncol Rep (2012) 0.82
Women with endometriosis have a higher DNA repair capacity and diminished breast cancer risk. Mol Cancer Biol (2013) 0.82
Relationship of lower uterine segment cancer with Lynch syndrome: a novel case with an hMLH1 germline mutation. Oncol Rep (2012) 0.82
RORα, a potential tumor suppressor and therapeutic target of breast cancer. Int J Mol Sci (2012) 0.82
Serological prevalence and persistence of high-risk human papillomavirus infection among women in Santiago, Chile. BMC Infect Dis (2014) 0.81
Breast and cervical cancer in 187 countries between 1980 and 2010. Lancet (2012) 0.81
Engaging in health behaviors to lower risk for breast cancer recurrence. PLoS One (2013) 0.81
Quality of screening with conventional Pap smear in Austria - a longitudinal evaluation. BMC Public Health (2013) 0.81
The Haiti Breast Cancer Initiative: Initial Findings and Analysis of Barriers-to-Care Delaying Patient Presentation. J Oncol (2013) 0.81
A lectin with highly potent inhibitory activity toward breast cancer cells from edible tubers of Dioscorea opposita cv. nagaimo. PLoS One (2013) 0.80
Prevalence of human papillomavirus infection among women presenting for cervical cancer screening in Chile, 2014-2015. Med Microbiol Immunol (2016) 0.80
History, biology, and health inequities: emergent embodied phenotypes and the illustrative case of the breast cancer estrogen receptor. Am J Public Health (2012) 0.80
Do socioeconomic factors influence breast cancer screening practices among Arab women in Qatar? BMJ Open (2015) 0.80
Knowledge and Beliefs of Breast Self-Examination and Breast Cancer among Market Women in Ibadan, South West, Nigeria. PLoS One (2015) 0.80
Beliefs and attitudes about breast cancer and screening practices among Arab women living in Qatar: a cross-sectional study. BMC Womens Health (2013) 0.80
Main controversies in breast cancer. World J Clin Oncol (2014) 0.80
Development of new estrogen receptor-targeting therapeutic agents for tamoxifen-resistant breast cancer. Future Med Chem (2013) 0.80
Precise Classification of Cervical Carcinomas Combined with Somatic Mutation Profiling Contributes to Predicting Disease Outcome. PLoS One (2015) 0.80
miR-182 induces cervical cancer cell apoptosis through inhibiting the expression of DNMT3a. Int J Clin Exp Pathol (2015) 0.80
Association of glutathione S-transferase T1, M1, and P1 polymorphisms in the breast cancer risk: a meta-analysis. Ther Clin Risk Manag (2016) 0.79
Expression of Smac induced by the Egr1 promoter enhances the radiosensitivity of breast cancer cells. Cancer Gene Ther (2014) 0.79
Benign and Malignant Breast Disease at Rwanda's First Public Cancer Referral Center. Oncologist (2016) 0.79
Oncogenic viral prevalence in invasive vulvar cancer specimens from human immunodeficiency virus-positive and -negative women in Botswana. Int J Gynecol Cancer (2014) 0.79
Household income is associated with the p53 mutation frequency in human breast tumors. PLoS One (2013) 0.79
Breast cancer survivors suffer from persistent postmastectomy pain syndrome and posttraumatic stress disorder (ORTHUS study): a study of the palliative care working committee of the Turkish Oncology Group (TOG). Support Care Cancer (2016) 0.79
Prevalence of and risk factors for high-risk human papillomavirus infection: a population-based study from Hetian, Xinjiang, China. Bosn J Basic Med Sci (2016) 0.78
Multitargeted antiangiogenic tyrosine kinase inhibitors combined to chemotherapy in metastatic breast cancer: a systematic review and meta-analysis. Eur J Clin Pharmacol (2014) 0.78
Breast cancer causes and treatment: where are we going wrong? Breast Cancer (Dove Med Press) (2013) 0.78
Wnt/β-catenin pathway is required for epithelial to mesenchymal transition in CXCL12 over expressed breast cancer cells. Int J Clin Exp Pathol (2015) 0.78
Distinct breast cancer subtypes in women with early-onset disease across races. Am J Cancer Res (2014) 0.78
Breast Cancer in Sub-Saharan Africa: Challenges and Opportunities to Reduce Mortality. Oncologist (2016) 0.78
A preoperative nomogram to predict the risk of synchronous distant metastases at diagnosis of primary breast cancer. Br J Cancer (2015) 0.78
No evidence for the involvement of XMRV or MCV in the pathogenesis of breast cancer. Br J Cancer (2012) 0.78
High rates of cervical cancer among HIV-infected women at a referral hospital in Malawi. Int J STD AIDS (2015) 0.78
Current Management Strategies in Breast Cancer by Targeting Key Altered Molecular Players. Front Oncol (2016) 0.78
Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 56.72
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 41.47
Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet (2006) 37.83
Maternal mortality for 181 countries, 1980-2008: a systematic analysis of progress towards Millennium Development Goal 5. Lancet (2010) 33.69
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 26.95
Selected major risk factors and global and regional burden of disease. Lancet (2002) 24.47
Household catastrophic health expenditure: a multicountry analysis. Lancet (2003) 20.07
Global malaria mortality between 1980 and 2010: a systematic analysis. Lancet (2012) 17.62
Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010. Lancet (2013) 16.76
Counting the dead and what they died from: an assessment of the global status of cause of death data. Bull World Health Organ (2005) 15.50
Progress towards Millennium Development Goals 4 and 5 on maternal and child mortality: an updated systematic analysis. Lancet (2011) 14.16
Financing of global health: tracking development assistance for health from 1990 to 2007. Lancet (2009) 13.41
Neonatal, postneonatal, childhood, and under-5 mortality for 187 countries, 1970-2010: a systematic analysis of progress towards Millennium Development Goal 4. Lancet (2010) 12.28
The preventable causes of death in the United States: comparative risk assessment of dietary, lifestyle, and metabolic risk factors. PLoS Med (2009) 12.13
Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010. Lancet (2012) 11.32
Public financing of health in developing countries: a cross-national systematic analysis. Lancet (2010) 11.22
Estimates of global mortality attributable to smoking in 2000. Lancet (2003) 10.52
The state of US health, 1990-2010: burden of diseases, injuries, and risk factors. JAMA (2013) 10.43
Global and regional burden of stroke during 1990-2010: findings from the Global Burden of Disease Study 2010. Lancet (2014) 10.06
Estimation of potential global pandemic influenza mortality on the basis of vital registry data from the 1918-20 pandemic: a quantitative analysis. Lancet (2006) 9.85
GBD 2010: design, definitions, and metrics. Lancet (2012) 8.64
Healthy life expectancy for 187 countries, 1990-2010: a systematic analysis for the Global Burden Disease Study 2010. Lancet (2012) 8.22
What has made the population of Japan healthy? Lancet (2011) 8.18
50-year trends in smoking-related mortality in the United States. N Engl J Med (2013) 7.80
Rapid health transition in China, 1990-2010: findings from the Global Burden of Disease Study 2010. Lancet (2013) 7.70
Age-specific and sex-specific mortality in 187 countries, 1970-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 7.62
Can we achieve Millennium Development Goal 4? New analysis of country trends and forecasts of under-5 mortality to 2015. Lancet (2007) 6.72
Causes of cancer in the world: comparative risk assessment of nine behavioural and environmental risk factors. Lancet (2005) 6.63
Trends in national and state-level obesity in the USA after correction for self-report bias: analysis of health surveys. J R Soc Med (2006) 6.11
UK health performance: findings of the Global Burden of Disease Study 2010. Lancet (2013) 6.11
Burden of depressive disorders by country, sex, age, and year: findings from the global burden of disease study 2010. PLoS Med (2013) 6.04
Measuring the global burden of disease. N Engl J Med (2013) 5.84
Social inequalities in male mortality, and in male mortality from smoking: indirect estimation from national death rates in England and Wales, Poland, and North America. Lancet (2006) 5.70
Civil registration systems and vital statistics: successes and missed opportunities. Lancet (2007) 5.67
Increased educational attainment and its effect on child mortality in 175 countries between 1970 and 2009: a systematic analysis. Lancet (2010) 5.36
Estimates of global and regional potential health gains from reducing multiple major risk factors. Lancet (2003) 5.26
Measuring the burden of neglected tropical diseases: the global burden of disease framework. PLoS Negl Trop Dis (2007) 4.87
Rethinking the "diseases of affluence" paradigm: global patterns of nutritional risks in relation to economic development. PLoS Med (2005) 4.64
Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study. Circulation (2013) 4.60
Monitoring global health: time for new solutions. BMJ (2004) 4.39
Validation of the symptom pattern method for analyzing verbal autopsy data. PLoS Med (2007) 4.35
Global and regional mortality from ischaemic heart disease and stroke attributable to higher-than-optimum blood glucose concentration: comparative risk assessment. Lancet (2006) 4.26
Validation of verbal autopsy procedures for adult deaths in China. Int J Epidemiol (2005) 4.20
Prevention of cardiovascular disease in high-risk individuals in low-income and middle-income countries: health effects and costs. Lancet (2007) 4.15
Comparability of self rated health: cross sectional multi-country survey using anchoring vignettes. BMJ (2004) 3.94
A systematic analysis of global anemia burden from 1990 to 2010. Blood (2013) 3.94